Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entospletinib + Vincristine in R/R B-cell NHL
NCT02568683Phase 2Terminated
- Sponsor
- Gilead Sciences
- Start
- Feb 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of entospletinib in B-cell non-Hodgkin lymphoma, sponsored by Gilead Sciences. Started Feb 2016; status: terminated.
02
Drugs
entospletinib
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT02568683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02568683.